The application of organoid models in research into metabolic diseases

Abstract Metabolic diseases have become a major threat to human health worldwide as a result of changing lifestyles. The exploration of the underlying molecular mechanisms of metabolic diseases and the development of improved therapeutic methods have been hindered by the lack of appropriate human experimental models. Organoids are three‐dimensional in vitro models of self‐renewing cells that spontaneously self‐organize into structures similar to the corresponding in vivo tissues, recapitulating the original tissue function. Off‐body organoid technology has been successfully applied to disease modelling, developmental biology, regenerative medicine, and tumour precision medicine. This new generation of biological models has received widespread attention. This article focuses on the construction process and research progress with regard to organoids related to metabolic diseases in recent years, and looks forward to their prospective applications.